How many pieces of data are we talking about for A
Post# of 144344
When Pfizer was trying to get its vaccine approved, I remember a researcher at Johns Hopkins saying his team could through the trial data for 40,000 patients in an afternoon, so why was it taking so long? I mean how many patients are we talking about here and much data?
For Amarex there appears to be "not doing your job" and really "not wanting to do your job" and I sure hope that NSF just bites the bullet and says this is not worth dragging our reputation through.